- Home
- BLDR vs IBRX Comparison
BLDR vs IBRX Comparison
Compare BLDR & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLDR | IBRX |
|---|---|---|
| Founded | 1998 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 7.2B |
| IPO Year | 2005 | 2015 |
Fundamental Metrics
Financial Performance| Metric | BLDR | IBRX |
|---|---|---|
| Price | $84.05 | $9.37 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 7 |
| Target Price | ★ $121.76 | $12.57 |
| AVG Volume (30 Days) | 2.3M | ★ 12.0M |
| Earning Date | 04-30-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.71 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $15,190,638,000.00 | $113,288,000.00 |
| Revenue This Year | $0.71 | $88.59 |
| Revenue Next Year | $4.52 | $131.15 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 668.31 |
| 52 Week Low | $65.10 | $1.95 |
| 52 Week High | $151.03 | $12.43 |
Technical Indicators
Market Signals| Indicator | BLDR | IBRX |
|---|---|---|
| Relative Strength Index (RSI) | 56.24 | 73.46 |
| Support Level | $74.63 | $6.69 |
| Resistance Level | $94.97 | $9.54 |
| Average True Range (ATR) | 4.14 | 0.56 |
| MACD | 0.83 | 0.25 |
| Stochastic Oscillator | 58.42 | 93.14 |
Price Performance
Historical ComparisonAbout BLDR Builders FirstSource Inc.
Builders FirstSource Inc is a manufacturer and supplier of building materials. The company offers structural and related building products such as factory-built roof and floor trusses, wall panels and stairs, vinyl windows, custom millwork and trim, and engineered wood. The products can be designed for each home individually and are installed by Builders FirstSource. The company's construction-related services include professional installation, turn-key framing, and shell construction. Builders FirstSource's customers range from large production builders to small custom homebuilders.
About IBRX ImmunityBio Inc.
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.